• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年精神科住院患者多重用药的预测因素。

Predictive factors for polypharmacy among child and adolescent psychiatry inpatients.

作者信息

Russell Paul S S, George Christina, Mammen Priya

机构信息

Child and Adolescent Psychiatry Unit, Department of Psychiatry, Christian Medical College, Vellore 632 002, India.

出版信息

Clin Pract Epidemiol Ment Health. 2006 Sep 22;2:25. doi: 10.1186/1745-0179-2-25.

DOI:10.1186/1745-0179-2-25
PMID:16995933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1584231/
Abstract

BACKGROUND

Aim was to determine the predictive factors for polypharmacy among inpatient children and adolescents with psychiatric disorders.

METHODS

Blinded, case-note review of children and adolescents with ICD 10 diagnosis of psychiatric disorders on psychotropic medication was conducted. Data on demography, illness, and treatment was analyzed with univariate and multivariate techniques.

RESULTS

Proscribing non-pharmacological interventions (OR = 4.7) and pro re nata medication (OR = 3.3), increased the risk of polypharmacy. Prescribing physical restraint reduced the risk of receiving multiple medications (OR = 0.3).

CONCLUSION

Proscribing non-pharmacological interventions, pro re nata medication and physical restraints increased polypharmacy.

摘要

背景

目的是确定患有精神疾病的住院儿童和青少年中多重用药的预测因素。

方法

对接受精神药物治疗且国际疾病分类第10版诊断为精神疾病的儿童和青少年进行盲法病例记录回顾。采用单变量和多变量技术分析人口统计学、疾病和治疗数据。

结果

未采用非药物干预措施(比值比=4.7)和按需给药(比值比=3.3)会增加多重用药风险。采用身体约束措施可降低接受多种药物治疗的风险(比值比=0.3)。

结论

未采用非药物干预措施、按需给药和身体约束措施会增加多重用药情况。

相似文献

1
Predictive factors for polypharmacy among child and adolescent psychiatry inpatients.儿童和青少年精神科住院患者多重用药的预测因素。
Clin Pract Epidemiol Ment Health. 2006 Sep 22;2:25. doi: 10.1186/1745-0179-2-25.
2
Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.精神药物的改变、多种药物治疗和自杀青少年住院患者早期再入院的风险。
Ann Pharmacother. 2009 Dec;43(12):1939-47. doi: 10.1345/aph.1M326. Epub 2009 Nov 24.
3
Psychotropic medication use in children and adolescents in an inpatient setting.住院环境下儿童和青少年使用精神药物的情况。
Psychiatriki. 2011 Oct-Dec;22(4):314-9.
4
Polypharmacy among children and adolescents with psychiatric disorders in a mental referral hospital in Botswana.博茨瓦纳一家精神专科医院中患有精神疾病的儿童和青少年的多重用药情况。
BMC Psychiatry. 2017 May 10;17(1):174. doi: 10.1186/s12888-017-1347-6.
5
Risk factors of psychotropic polypharmacy in the treatment of children and adolescents with psychiatric disorders.精神障碍儿童和青少年治疗中精神药物联用的风险因素。
Res Social Adm Pharm. 2019 Apr;15(4):395-403. doi: 10.1016/j.sapharm.2018.06.005. Epub 2018 Jun 13.
6
National trends in psychotropic medication polypharmacy in office-based psychiatry.基于办公室的精神病学中精神药物联合用药的全国趋势。
Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.
7
Pro re nata medication for psychiatric inpatients: time to act.精神科住院患者的按需给药:是时候采取行动了。
Aust N Z J Psychiatry. 2008 Jul;42(7):555-64. doi: 10.1080/00048670802119804.
8
Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital.加拿大一家精神病医院按需用药情况的描述性分析。
Int J Ment Health Nurs. 2017 Aug;26(4):402-408. doi: 10.1111/inm.12265. Epub 2016 Nov 2.
9
National time trend changes in psychotropic medication of child and adolescent psychiatric inpatients across Finland.芬兰儿童和青少年精神科住院患者精神药物治疗的全国时间趋势变化
Child Adolesc Ment Health. 2018 May;23(2):63-70. doi: 10.1111/camh.12217. Epub 2017 Mar 30.
10
Psychotropic medication utilization in a child and adolescent mental health service.儿童和青少年心理健康服务中精神药物的使用情况。
J Child Adolesc Psychopharmacol. 2006 Jun;16(3):273-85. doi: 10.1089/cap.2006.16.273.

引用本文的文献

1
Current Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patients.儿童和青少年患者的精神共病和精神药物处方的当前模式。
Medicina (Kaunas). 2019 May 17;55(5):159. doi: 10.3390/medicina55050159.
2
Prescribing pattern of psychotropic medications in child psychiatric practice in a mental referral hospital in Botswana.博茨瓦纳一家精神科转诊医院儿童精神科实践中精神药物的处方模式。
Pan Afr Med J. 2017 Feb 21;26:83. doi: 10.11604/pamj.2017.26.83.11212. eCollection 2017.
3
Polypharmacy among children and adolescents with psychiatric disorders in a mental referral hospital in Botswana.博茨瓦纳一家精神专科医院中患有精神疾病的儿童和青少年的多重用药情况。
BMC Psychiatry. 2017 May 10;17(1):174. doi: 10.1186/s12888-017-1347-6.
4
Prescribing Patterns and Perceptions of Health Care Professionals About Rational Drug use in a Specialist Hospital Clinic.专科医院门诊医护人员关于合理用药的处方模式及认知
J Public Health Afr. 2014 Dec 19;5(2):242. doi: 10.4081/jphia.2014.242. eCollection 2014 Jun 29.
5
Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.精神药物多药联用及超说明书用药的预测因素:一项针对儿童和青少年精神科医生的全国性调查。
J Psychiatr Pract. 2014 Nov;20(6):438-47. doi: 10.1097/01.pra.0000456592.20622.45.
6
Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs.儿童和青少年精神障碍的联合药物治疗:流行率、疗效、风险和研究需求。
Paediatr Drugs. 2013 Oct;15(5):377-91. doi: 10.1007/s40272-013-0032-6.

本文引用的文献

1
Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription.多重用药与过量给药:精神科医生对抗精神病药物处方的认知
Br J Psychiatry. 2005 Sep;187:243-7. doi: 10.1192/bjp.187.3.243.
2
Increasing use of psychotropic medications in children and adolescents: what does it mean?儿童和青少年中精神药物使用的增加:这意味着什么?
J Child Adolesc Psychopharmacol. 2003 Spring;13(1):1-3. doi: 10.1089/104454603321666126.
3
Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint.
J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):4S-25S. doi: 10.1097/00004583-200202001-00002.
4
Efficacy and effectiveness of child and adolescent psychotherapy and pharmacotherapy.儿童及青少年心理治疗与药物治疗的疗效和有效性。
Ment Health Serv Res. 1999 Sep;1(3):125-57. doi: 10.1023/a:1022321812352.
5
The use of psychotropic medications in young children: the facts, the controversy, and the practice.幼儿使用精神药物:事实、争议与实践。
Conn Med. 2000 Jun;64(6):329-33.
6
[The use of psychotropic drugs in an Italian psychiatric hospital: a two-year-long follow-up study].[意大利一家精神病院精神药物的使用:一项为期两年的随访研究]
Epidemiol Psichiatr Soc. 1999 Oct-Dec;8(4):262-9. doi: 10.1017/s1121189x00008174.
7
Combined pharmacotherapy: pitfalls of treatment.
J Am Acad Child Adolesc Psychiatry. 1999 Nov;38(11):1455-7. doi: 10.1097/00004583-199911000-00021.
8
Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice.美国儿童精神活性药物的处方实践:研究与临床实践之间的差距。
J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):557-65. doi: 10.1097/00004583-199905000-00017.
9
Overzealous prescribing of medications.药物的过度处方。
J Am Acad Child Adolesc Psychiatry. 1998 Sep;37(9):900-1. doi: 10.1097/00004583-199809000-00003.
10
Combined pharmacotherapy in children and adolescents in a residential treatment center.寄宿治疗中心儿童和青少年的联合药物治疗
J Am Acad Child Adolesc Psychiatry. 1997 Feb;36(2):248-54. doi: 10.1097/00004583-199702000-00016.